Literature DB >> 6835125

The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease.

K W Faulkner, A K House, W M Castleden.   

Abstract

A study of the accumulative survival rates of 133 patients with symptomatic peripheral vascular disease was carried out comparing the survival rates of tobacco smokers and non-smokers. Within the smoking group, those who continued to smoke after the surgery were compared to those who ceased smoking. Of these patients with peripheral vascular disease, 86% were, or had been, smokers. Their survival rates were less than for those who had never been smokers. Of the smoking group, those who claimed to have ceased smoking had almost twice the chance of surviving five years than those who continued to smoke. From these data, we conclude that it is never too late to stop the smoking habit.

Entities:  

Mesh:

Year:  1983        PMID: 6835125     DOI: 10.5694/j.1326-5377.1983.tb99395.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  16 in total

Review 1.  Pharmacological treatment of patients with peripheral arterial disease.

Authors:  Chin K Kim; Carsten M Schmalfuss; Richard S Schofield; David S Sheps
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.

Authors:  Gurbir Dhaliwal; Debabrata Mukherjee
Journal:  Int J Angiol       Date:  2007

Review 3.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

4.  Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Authors:  Neha J Pagidipati; Ann Marie Navar; Karen S Pieper; Jennifer B Green; M Angelyn Bethel; Paul W Armstrong; Robert G Josse; Darren K McGuire; Yuliya Lokhnygina; Jan H Cornel; Sigrun Halvorsen; Timo E Strandberg; Tuncay Delibasi; Rury R Holman; Eric D Peterson
Journal:  Circulation       Date:  2017-06-16       Impact factor: 29.690

Review 5.  Intermittent claudication. An update on management.

Authors:  P A Blombery
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

6.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Am Coll Cardiol       Date:  2011-10-06       Impact factor: 24.094

Review 7.  2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  Catheter Cardiovasc Interv       Date:  2011-09-29       Impact factor: 2.692

8.  Management of Critical Limb Ischemia.

Authors:  Scott Kinlay
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

Review 9.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 10.  Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.

Authors:  Taisei Kobayashi; Sahil A Parikh; Jay Giri
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.